VVOS
Vivos Therapeutics, Inc. Common Stock
stockNASDAQ
vivos therapeutics, inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (sdb) comprising mild-to-moderate obstructive sleep apnea (osa). the company's solutions cover proprietary alternatives for treating mild-to-moderate osa; craniofacial and anatomical anomalies that are associated with mild-to-moderate osa. its treatment for osa involves specially designed and customized oral appliances and treatment protocols. the company, through its vivos integrated healthcare network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate osa. vivos therapeutics, inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. it caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers,
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.15 | 2026-10-09 | -12.63% | 7.202 |
| 1M | 0.18 | 2026-09-17 | -26.08% | 2.609 |
| 3M | 0.42 | 2026-07-17 | -68.99% | 3.419 |
| 6M | 0.97 | 2026-04-17 | -86.64% | 1.185 |
| 1Y | 2.90 | 2025-10-17 | -95.51% | 1.355 |
| 2Y | 2.44 | 2024-10-17 | -94.67% | — |
| 5Y | 97.00 | 2021-10-18 | -99.87% | 0.812 |
Vivos Therapeutics, Inc. Common Stock (NASDAQ:VVOS) stock price today is $0.13, and today's volume is 1,617,761. VVOS is down 8.894% today. The 30 day average volume is 6.08M. VVOS market cap is $2.62M with 20.12M shares outstanding.